ATEC Announces Closing of Public Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Stock
16 Octobre 2020 - 10:01PM
Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of
innovative spine surgery solutions dedicated to revolutionizing the
approach to spine surgery, today announced the closing of its
previously announced underwritten public offering of 13,142,855
shares of its common stock, which includes the full exercise of the
underwriters’ option to purchase 1,714,285 additional shares of
common stock, at a public offering price of $8.75 per share, for
total gross proceeds of approximately $115.0 million, before
deducting underwriting discounts and commissions and estimated
offering expenses payable by ATEC.
Morgan Stanley and Cowen acted as joint
book-running managers in the offering. Canaccord Genuity acted
as lead manager in the offering, with Lake Street Capital
Markets and Northland Capital Markets acting as
co-managers.
The shares of common stock were offered pursuant
to a shelf registration statement on Form S-3 (File
No. 333-241677) previously filed with and declared effective
by the Securities and Exchange Commission. The offering was
made by means of a prospectus supplement and the accompanying
prospectus. A preliminary prospectus supplement and accompanying
prospectus relating to the offering were filed previously with
the SEC and are available on the SEC’s website
at www.sec.gov. The final prospectus supplement and
accompanying base prospectus will be filed with
the SEC and available on the SEC’s website thereafter,
and, when available, may also be obtained from Morgan Stanley
& Co. LLC, Attention: Prospectus Department, 180 Varick Street,
2nd Floor, New York, New York 10014, or by e-mail at
prospectus@morganstanley.com or Cowen and Company, LLC, at c/o
Broadridge Financial Solutions, Attn: Prospectus Department, 1155
Long Island Avenue, Edgewood, NY 11717, by telephone at (833)
297-2926 or by email at PostSaleManualRequests@broadridge.com.
This press release shall not constitute an offer
to sell nor the solicitation of an offer to buy, nor shall there be
any sale of these securities in any state or jurisdiction in which
such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such
state or jurisdiction.
About ATEC
Alphatec Holdings, Inc. (ATEC), through its
wholly-owned subsidiaries, Alphatec Spine,
Inc. and SafeOp Surgical, Inc., is a medical device
company dedicated to revolutionizing the approach to spine surgery
through clinical distinction. ATEC’s Organic Innovation Machine is
focused on developing new approaches that integrate seamlessly with
the SafeOp Neural InformatiX System to safely and reproducibly
treat spine’s various pathologies and achieve the goals of spine
surgery. Alphatec’s vision is to become the Standard Bearer in
Spine. For more information, visit us
at www.atecspine.com.
Company Contact:Jeff BlackChief
Financial Officerinvestorrelations@atecspine.com
Investor/Media Contact:Tina
JacobsenInvestor Relations(760)
494-6790investorrelations@atecspine.com
Alphatec (NASDAQ:ATEC)
Graphique Historique de l'Action
De Juil 2024 à Août 2024
Alphatec (NASDAQ:ATEC)
Graphique Historique de l'Action
De Août 2023 à Août 2024